ストックスクリーナーアプリを入手
25.21
2.74%
-0.71
アフターアワーズ：
25.25
0.04
+0.16%
Pfizer Inc (PFE) 最新ニュース
Pfizer StockWeekly sector check after pneumococcal vaccine update - AD HOC NEWS
mRNA Patent Wars Update: Delaware Court Allows Moderna and Pfizer/BioNTech to Assert Laches in GSK Patent Infringement Cases - JD Supra
Appeals Court Scraps Redo Of Pfizer, Flynn Drug Fines - Law360
PFE Stock Slides Following CFO Exit, 2026 Guidance Reaffirmed - TradingView
Pfizer shares dip after CFO departure raises new questions about 2026 outlook - TechStock²
Pfizer CEO on leaving Europe in pursuit of the American dream: The ‘opportunities are enormous’ - New York Post
Key facts: Pfizer Reaffirms FY26; CFO Denton Exits Aug 15; Guegan Int. - TradingView
Pfizer reaffirms outlook after CFO exit (update) - MSN
Pfizer reaffirms 2026 financial guidance following CFO transition By Investing.com - Investing.com India
Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook - Yahoo Finance
Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook - The Motley Fool
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Pfizer Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Pfizer CFO departs for consumer goods sector - CFO Dive
Pfizer Shares Dip 1.5% as CFO Dave Denton Announces Exit - TradingView
Pfizer CFO Exit Adds Pressure - TradingView
Pfizer reaffirms 2026 financial guidance following CFO transition - Investing.com
Pfizer reaffirms outlook after CFO exit (update) (PFE:NYSE) - Seeking Alpha
Pfizer reafffirms 2026 guidance after CFO transition announcement By Investing.com - Investing.com Canada
Pfizer reafffirms 2026 guidance after CFO transition announcement - Investing.com
Pfizer Stock Drops Today As CFO Steps Down In August - Benzinga
Pfizer (PFE) Names Cecile Guegan Interim CFO As Dave Denton Prepares To Exit - Yahoo Finance
Why Accenture, Pfizer, and Kroger are moving today - Yahoo Finance
Pfizer Slides as Investors Appear to Reassess Near-Term Growth Catalysts - Quiver Quantitative
Pfizer (PFE) Shares Sink 3% Following CFO Dave Denton’s Resignation Announcement - Blockonomi
Pfizer (PFE) Shares Slide 3% Following CFO Dave Denton’s Departure Announcement - Blockonomi
Pfizer (PFE) Shares Sink After Surprise CFO Exit - TipRanks
Pfizer CFO Dave Denton to step down, interim CFO appointed - grafa.com
Pfizer Names Cecile Guegan Interim CFO Following Dave Denton’s Departure - citybiz
Pfizer CFO Dave Denton to leave company in August - Reuters
Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space? - Yahoo Finance
Pfizer launches CFO search as Denton plans to depart in August - Crain's New York Business
Pfizer Announces Search for New Chief Financial Officer - Contract Pharma
Living Longer with Cancer: Redefining What It Means to Survive - Pfizer
Pfizer supporting employees with migraine through flexible work arrangements, raising awareness about condition - Benefits Canada.com
Pfizer Shares Slip Following CFO Transition Announcement - Yahoo Finance
Pfizer CFO Dave Denton to step down, leave company in August - BNN Bloomberg
Pfizer CFO Dave Denton stepping down in August 2026 - Yahoo Finance
Pfizer CFO Dave Denton to return to consumer goods roots - FirstWord Pharma
Pfizer Launches CFO Search as Denton Plans to Depart in August - Bloomberg.com
Pfizer CFO Dave Denton to step down, Cecile Guegan named interim - Investing.com
Pfizer stock falls as CFO Dave Denton to step down in August - Investing.com
Pfizer CFO Dave Denton to Step Down; Cecile Guegan Named Interim CFO - TradingView
Pfizer Chief Financial Officer Dave Denton to Leave - marketscreener.com
Pfizer Announces Chief Financial Officer Transition - Business Wire
Pfizer CFO Dave Denton to Depart; Interim CFO Named - marketscreener.com
Pfizer CFO Dave Denton to step down in August - Breakingthenews.net
Pfizer Inc. (PFE) Discusses New Phase IIb Data and Development Plans for Berobenatide GLP-1 Receptor Agonist in ObesitySlideshow (NYSE:PFE) 2026-06-17 - Seeking Alpha
Pfizer: Why I'm Still Expecting A Massive Rebound (NYSE:PFE) - Seeking Alpha
Pfizer Stock And Two AI Healthcare Plays That Look Mispriced - simplywall.st
Questions over Pfizer’s marketing claims resurface as scrutiny grows around blockbuster drug promotion - EU Reporter
Rigel to roll out Veppanu in August; Arvinas, Pfizer snag $70M upfront on cleared deal - Seeking Alpha
Pfizer (PFE) Expands China Partnership With SINOPHARM Around Diflucan And Future Launches - Yahoo Finance
Pfizer trades up with Rigel’s Veppanu deal done - TechStock²
Judge Allows Pfizer, Moderna Defenses In GSK Vax IP Dispute - Law360
Pfizer Agrees To Deal To End Depo-Provera MDL - Law360
Arvinas, Pfizer receive $70M upfront as Rigel deal for VEPPANU clears HSR - TradingView
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? - 24/7 Wall St.
The Zacks Analyst Blog Highlights Pfizer, Altria, Newmont, Koil Energy and Stratus Properties - Yahoo Finance
Pfizer’s Dividend Has Grown Every Year Since 2021, and the Stock Still Yields Over 6% - TIKR.com
Top Research Reports for Pfizer, Altria & Newmont Corp. - Yahoo Finance
Pfizer Inc. Stock (US7170811035): Analyst Views And Valuation In Focus After Quiet Start To The Week - AD HOC NEWS
Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth - Yahoo Finance
Is Pfizer's Discounted Valuation a Buying Opportunity or a Value Trap? - Yahoo Finance
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know - Yahoo Finance
Dr Reddy’s challenges Pfizer with US launch of Bosutinib - The Pharma Letter
1.35%
大文字化:
|
ボリューム (24 時間):